Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1906 1
1946 2
1947 1
1949 1
1950 3
1951 3
1952 4
1953 2
1954 5
1955 1
1956 1
1957 1
1958 2
1959 8
1960 4
1961 3
1962 1
1963 5
1964 6
1965 1
1966 9
1967 2
1968 3
1969 6
1970 6
1971 10
1972 8
1973 6
1974 9
1975 14
1976 10
1977 13
1978 9
1979 11
1980 17
1981 12
1982 15
1983 15
1984 14
1985 12
1986 14
1987 20
1988 13
1989 16
1990 14
1991 12
1992 17
1993 12
1994 17
1995 18
1996 19
1997 13
1998 16
1999 21
2000 20
2001 27
2002 16
2003 10
2004 14
2005 21
2006 12
2007 17
2008 20
2009 14
2010 21
2011 25
2012 32
2013 29
2014 25
2015 21
2016 19
2017 23
2018 27
2019 22
2020 20
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

859 results
Results by year
Filters applied: . Clear all
Page 1
Improved survival with MEK inhibition in BRAF-mutated melanoma.
Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D; METRIC Study Group. Flaherty KT, et al. Among authors: sherman lj. N Engl J Med. 2012 Jul 12;367(2):107-14. doi: 10.1056/NEJMoa1203421. Epub 2012 Jun 4. N Engl J Med. 2012. PMID: 22663011 Free article. Clinical Trial.
From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS. Ferner RE, et al. Among authors: sherman ls. Am J Med Genet A. 2019 Jun;179(6):1098-1106. doi: 10.1002/ajmg.a.61112. Epub 2019 Mar 25. Am J Med Genet A. 2019. PMID: 30908866 Free PMC article.
Deficit, difference, or both? Autism and neurodiversity.
Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T. Kapp SK, et al. Among authors: sherman le. Dev Psychol. 2013 Jan;49(1):59-71. doi: 10.1037/a0028353. Epub 2012 Apr 30. Dev Psychol. 2013. PMID: 22545843
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.
Steensma DP, Fenaux P, Van Eygen K, Raza A, Santini V, Germing U, Font P, Diez-Campelo M, Thepot S, Vellenga E, Patnaik MM, Jang JH, Varsos H, Bussolari J, Rose E, Sherman L, Sun L, Wan Y, Dougherty S, Huang F, Feller F, Rizo A, Platzbecker U. Steensma DP, et al. Among authors: sherman l. J Clin Oncol. 2021 Jan 1;39(1):48-56. doi: 10.1200/JCO.20.01895. Epub 2020 Oct 27. J Clin Oncol. 2021. PMID: 33108243 Clinical Trial.
CD44: from adhesion molecules to signalling regulators.
Ponta H, Sherman L, Herrlich PA. Ponta H, et al. Among authors: sherman l. Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45. doi: 10.1038/nrm1004. Nat Rev Mol Cell Biol. 2003. PMID: 12511867 Review.
Wendy Havran 1955-2020.
Sherman LA. Sherman LA. Nat Immunol. 2020 Apr;21(4):357. doi: 10.1038/s41590-020-0638-0. Nat Immunol. 2020. PMID: 32205886 No abstract available.
Mesenchymal stem cell therapies in brain disease.
Sherman LS, Romagano MP, Williams SF, Rameshwar P. Sherman LS, et al. Semin Cell Dev Biol. 2019 Nov;95:111-119. doi: 10.1016/j.semcdb.2019.03.003. Epub 2019 Apr 4. Semin Cell Dev Biol. 2019. PMID: 30922957 Review.
859 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page